CM Management »

Cartesian Therapeutics shares owned by CM Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by CM Management from 13F filings

Historical chart of CM Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by CM Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by CM Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $625k 60k 10.42

More positions owned by CM Management

Rigel Pharmaceuticals (RIGL)
Ali (ALCO)
Royalty Pharma Com - Class A (RPRX)
Radiant Logistics (RLGT)
Bgc Group Com - Class A (BGC)
Everest Re Group (EG)
MarineMax (HZO)
Copa Holdings Sa Com - Class A (CPA)
Organon & Co (OGN)
Columbus McKinnon (CMCO)
Newmark Group Com - Class A (NMRK)
Shoulder Innovations (SI)
Coherus Biosciences (CHRS)
Republic Bancorp Ky Com - Class A (RBCAA)
Park Hotels & Resorts Inc-wi (PK)

View all positions for CM Management

Top funds holding Cartesian Therapeutics

Squarepoint Ops
BlackRock
683 Capital Management
Vanguard Capital Management
FMR
Geode Capital Management
AQR Capital Management
Millennium Management
Two Sigma Investments
Marshall Wace
UBS Group
Jupiter Topco
State Street Corporation
Privium Fund Management B.V.
Susquehanna International

View all funds holding Cartesian Therapeutics